Novartis wins FDA OK of low-dose COPD therapy - FierceBiotech
Links shared publicly online about this topic.
- 169total visits
Novartis wins FDA OK of low-dose COPD therapy - FierceBiotech
Two years after the FDA originally stiff-armed Novartis on indacaterol inhalation powder regulators finally gave the COPD treatment a green light at a low dose. Word of the approval spread late on Read more...
View full resource at fiercebiotech.com
Most Recently Shared on July 5, 2011 at 12:45 pm By:
Novartis wins FDA OK of low-dose COPD therapy. http://bit.ly/kaYv10
Advertisement
